Trial NCT03422094

View at ClinicalTrials.gov 
Org. Study IDs: 201804195

Last trial update was posted on 2021-10-27

MeSH Interventions

Ipilimumab Nivolumab Poly ICLC

MeSH Conditions

Glioblastoma

Other Conditions


Stopping Reasons

Manufacturer changed focus to cell therapy

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID